সোমবার, ২৫ ফেব্রুয়ারী, ২০১৩

Intersect ENT Lands $30M From Norwest, Kleiner, USVP & More For Its Innovative Sinus Drug & Device Combo

logo_lgIn August 2011, Intersect won approval from the FDA for Propel, which, simply put, is a stent that doctors implant in the sinuses after surgery to help keep them open. The cool part is that, over time, the stent absorbs into the patient's body post-surgery (so that follow-up surgery isn't required), slowly releasing a steroid to help control local inflammation, according to Medgadget. In the fall of last year, the company won approval again for the Propel Mini, a miniaturized version of its flagship product designed for "less extensive surgeries," Medgadget says.

Source: http://feedproxy.google.com/~r/Techcrunch/~3/MOWvOOQwBkY/

Fun carrie underwood jack white wiz khalifa ll cool j Presidents Day 2013 2013 Grammys

কোন মন্তব্য নেই:

একটি মন্তব্য পোস্ট করুন